Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel.

Autor:	Kantelhardt, Eva J.1 eva.kantelhardt@medizin.uni-halle.de, Vetter, Martina1, Schmidt, Marcus2, Veyret, Corinne3, Augustin, Doris4, Hanf, Volker5, Meisner, Christoph6, Paepke, Daniela7, Schmitt, Manfred7, Sweep, Fred8, Minckwitz, Gunter von9, Martin, Pierre-Marie10, Jaenicke, Fritz11, Thomssen, Christoph1, Harbeck, Nadia12
Zdroj:	BMC Cancer. 2011, Vol. 11 Issue 1, p140-149. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu